100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human RNF-111 (E3 ubiquitin-protein ligase Arkadia) ELISA Kit (AEFI00211)

SKU AEFI00211
Product Type ELISA Kit
Size 48T/96T
Reactivity Human
Detection Method Sandwich ELISA, Double Antibody
Sensitivity 0.094 ng/mL
Range 0.156-10 ng/mL
$857

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human RNF-111 (E3 ubiquitin-protein ligase Arkadia) ELISA Kit

The Human RNF-111 E3 ubiquitin protein ligase (Arkadia) ELISA Kit is a powerful tool for the accurate measurement of RNF-111 levels in human samples including serum, plasma, and cell culture supernatants. This kit offers outstanding sensitivity and specificity, guaranteeing precise and reproducible results for a variety of research needs.RNF-111, also known as Arkadia, is a key enzyme involved in the ubiquitination process, playing a critical role in protein regulation and cellular homeostasis.

Dysregulation of RNF-111 has been linked to various diseases such as cancer, inflammatory disorders, and autoimmune conditions, highlighting its importance as a potential biomarker for disease diagnosis and therapeutic development.With its advanced technology and reliable performance, the Human RNF-111 E3 ubiquitin protein ligase (Arkadia) ELISA Kit is an essential tool for researchers studying the molecular mechanisms of disease and exploring new treatment strategies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose